Dulaglutide vs Fragment 176-191
Overview
Dulaglutide and Fragment 176-191 are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Dulaglutide and Fragment 176-191 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Dulaglutide | Fragment 176-191 | |
|---|---|---|
| Category | Weight Management & Metabolic | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | Research use only |
| Typical dosage | 0.75-4.5 mg | 250-500 mcg |
| Frequency | weekly | daily |
| Reported benefits | Blood sugar control, weight management, cardiovascular benefits | Fat metabolism, no effect on blood sugar or insulin |
| Reported side effects | Nausea, diarrhea, injection site reactions | Minimal reported side effects |
Key differences
Primary use. Dulaglutide is categorised under Weight Management & Metabolic, while Fragment 176-191 falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Dulaglutide: FDA-approved. Fragment 176-191: not FDA-approved; treated as a research compound.
Dosing. Dulaglutide is typically dosed at 0.75-4.5 mg (weekly). Fragment 176-191 is typically dosed at 250-500 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Dulaglutide and Fragment 176-191 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Dulaglutide and Fragment 176-191?
- Dulaglutide and Fragment 176-191 are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. Dulaglutide is FDA-approved for one or more indications, whereas Fragment 176-191 is not FDA-approved; generally classified as a research compound.
- What is Dulaglutide used for?
- Weekly GLP-1 (Trulicity).
- What is Fragment 176-191 used for?
- HGH fragment for fat loss.
- Can you take Dulaglutide and Fragment 176-191 together?
- Some users combine peptides within a single protocol, but stacking Dulaglutide and Fragment 176-191 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Dulaglutide or Fragment 176-191 FDA-approved?
- Dulaglutide is FDA-approved for one or more indications. Fragment 176-191 is not FDA-approved; generally classified as a research compound.
Read the full articles
- Dulaglutide — full monograph: mechanism, research, dosing & references
- Fragment 176-191 — full monograph: mechanism, research, dosing & references